Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEZ235 plus Paclitaxel in HER2- Breast Cancer
NCT01495247Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jan 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of dactolisib in breast cancer, sponsored by Novartis. Started Jan 2012; status: terminated.
02
Drugs
dactolisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01495247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495247.